In this episode, we explore whether a reductionist approach in cancer research is a limitation—or an opportunity. Bioprinting is emerging as a transformative technology that enables the creation of complex 3D tumor models, allowing researchers to study cancer in ways that better reflect human physiology. We discuss how bioprinting addresses the shortcomings of traditional 2D cultures and animal models, and how it empowers scientists to isolate and examine specific variables within the tumor microenvironment. From personalized tumor models to high-throughput drug screening and ethical advantages, bioprinting is reshaping the path toward more predictive and effective therapies. Join us as we ask: is this simplification actually the key to unlocking complexity?